WhitTier Trust Company’s Crinetics Pharmaceuticals CRNX Stock Holding History

WhitTier Trust Company’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.51K	Hold	66	–	–	﹤0.01%	1156
2026 Q1	$2.49K	Buy	66 +36	+120%	+$1.61K	﹤0.01%	1246
2025 Q4	$1.38K	Hold	30	–	–	﹤0.01%	1196
2025 Q3	$1.23K	Hold	30	–	–	﹤0.01%	1201
2025 Q2	$862	Hold	30	–	–	﹤0.01%	1366
2025 Q1	$1.01K	Hold	30	–	–	﹤0.01%	1337
2024 Q4	$1.53K	Hold	30	–	–	﹤0.01%	1258
2024 Q3	$1.53K	Hold	30	–	–	﹤0.01%	1244
2024 Q2	$1.34K	Hold	30	–	–	﹤0.01%	1195
2024 Q1	$1.4K	Buy	+30	New	+$1.17K	﹤0.01%	1151

Other funds holding CRNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

BSA

Braun Stacey Associates New York $3.53B AUM 63.32% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

WhitTier Trust Company's CRNX Position: Q2 2026 in Review

WhitTier Trust Company held its Crinetics Pharmaceuticals (CRNX) position steady in Q2 2026 at 66 shares worth $5.51K. The position accounts for ﹤0.01% of the portfolio, ranked #1156.

WhitTier Trust Company first reported a position in CRNX in Q1 2024 and has held it in 10 quarters since. 100 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

WhitTier Trust Company held 66 shares of Crinetics Pharmaceuticals worth $5.51K as of Q2 2026.
WhitTier Trust Company left its Crinetics Pharmaceuticals share count unchanged in Q2 2026.
Crinetics Pharmaceuticals made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #1156 holding.
WhitTier Trust Company first reported a position in Crinetics Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
100 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.